جستجوی استاد راهنمای دانشگاهی

• Otolaryngology
• Neuro-otology
• Audiovestibular Medicine
• +۶ مورد دیگر

Georgios Korres currently serves as a Visiting Assistant Professor in the Department of Otolaryngology (ENT) at the University of Athens, School of Medicine. He holds a PhD (2009) and MD (2006) from the University of Athens, specializing in ENT and Neuro-otology, along with a BSc (Hons) in Cell and Molecular Biology from Anglia Ruskin University (1999). Academic Qualifications PhD in ENT (University of Athens, 2009) MD in Medicine (University of Athens, 2006) BSc (Hons) in Cell and Molecular Biology (Anglia Ruskin University, 1999) His research focuses on vestibular disorders , occupational hearing loss , genetic factors in hearing impairment , and ENT surgical outcomes . Recent work includes systematic reviews on otosclerosis treatments and dizziness in COVID-19 patients, as well as investigations into cervical VEMP recordings post-stapedotomy and autoimmune vestibulopathy. Notable collaborations include projects at the Royal National Throat, Nose and Ear Hospital (UCL) and Central Manchester University Hospitals. He also contributes to the editorial board of Brain Sciences Journal and participates in the European Board Examination of Otorhinolaryngology.

• Nephrology
• Biomineralization
• Health Informatics
• +۳ مورد دیگر

Jessica Saw serves as a Teaching Professor at the Carle Illinois College of Medicine, University of Illinois Urbana-Champaign, where she directs the Renal program within Biomedical and Translational Sciences. Her instructional responsibilities include teaching Renal (BSE 633) and Human Anatomy & Physiology Laboratory courses (MCB 245/247), emphasizing hands-on medical education for future physicians. Her research spans nephrology, biomineralization, and health informatics, with dual focus on kidney stone pathophysiology and health data communication. She investigates microbial entombment in urolithiasis, in vivo stone dissolution mechanisms, and develops visual hierarchies for health data. Additional interests include bedside art interventions for oncology patients and translational studies in diabetic gastroparesis, reflecting her commitment to patient-centered innovation. Publication analysis reveals three dominant research trajectories: (1) Geobiological studies of kidney stones (2018-2021) demonstrating microbial roles in biomineralization, (2) Health informatics work (2023-2024) addressing infodemics and data visualization, and (3) Clinical interventions (2014-2018) exploring pharmacological pathways and non-pharmacological therapies. Her work consistently bridges basic science with clinical applications in renal health and patient experience optimization.

• Microbial Pathogenesis
• Lipidomics
• Inflammation
• +۴ مورد دیگر

Alison J. Scott is an Assistant Professor at the University of Maryland, Baltimore School of Dentistry in the Department of Microbial Pathogenesis, with an adjunct appointment in the Department of Microbiology & Immunology. Her research focuses on host-directed therapies for infectious diseases through lipid response analysis during inflammation. Her educational background includes: Postdoctoral Fellowship (2015-2016) at the University of Maryland, Baltimore under Dr. David Goodlett PhD in Molecular Microbiology & Immunology (2015) from the University of Maryland, Baltimore under Dr. Robert Ernst BS in Analytical Biochemistry (2004) from Eastern Michigan University Dr. Scott's research centers on lipid-driven inflammatory mechanisms in infectious and sterile pathologies. Using cutting-edge mass spectrometry imaging , her lab maps lipidomic and metabolomic dynamics at the host-pathogen interface to identify therapeutic targets. Key emphases include: Lipid-mediated pathogenesis in TLR4-stealth infections (e.g., Francisella) Development of 3D imaging techniques for pulmonary infection models Application of lipid modulation in neurodegeneration linked to sterile inflammation Her 2016-2019 publications reveal a cohesive trajectory in mass spectrometry imaging innovation, specifically advancing simultaneous visualization of host-pathogen lipid interactions and structural lipid modifications affecting immune responses. This work establishes lipids as central mediators in infection pathogenesis and sterile inflammatory conditions. No scientific awards are highlighted in the provided documentation. While specific advisees and grant details aren't documented, her laboratory actively develops host-directed therapeutic strategies using bespoke lipids across pulmonary infection and neurodegeneration models, indicating ongoing research funding and mentorship activities. Her laboratory integrates lipidomic/metabolomic mapping with advanced imaging to decode disease mechanisms, currently operating across multiple experimental systems including Francisella infection models, sterile inflammation platforms, and neurodegeneration-linked immune response assays.

Johanna B. Holmمشاهده پروفایل

استادیار

• Vaginal Microbiome
• Women's Reproductive Health
• Sexually Transmitted Infections
• +۴ مورد دیگر

Johanna B. Holm is an Assistant Professor in the Department of Microbiology and Immunology at the University of Maryland School of Medicine, where she also holds appointments as a Member of the Institute for Genome Sciences and the Center for Advanced Microbiome Research and Innovation. Her laboratory integrates computational and experimental approaches to investigate the vaginal microbiome's role in women's reproductive health, with a focus on bacterial vaginosis (BV) and sexually transmitted infections (STIs). Her educational journey began with undergraduate research at Millersville University of Pennsylvania in Dr. Jean Boal's cephalopod laboratory, where she studied learning and communication in marine invertebrates. She earned her Ph.D. in Marine and Environmental Biology from the University of Southern California under Dr. Karla Heidelberg, conducting foundational work on coral-associated microbiomes and hypersaline lake ecology. Her postdoctoral training occurred in the laboratories of Dr. Rebecca Brotman and Dr. Jacques Ravel at the University of Maryland School of Medicine. Dr. Holm's research centers on defining microbial and molecular mechanisms by which cervicovaginal microbiota modulate host susceptibility to pathogens like Chlamydia trachomatis and Trichomonas vaginalis . Her lab develops bioinformatic tools for high-resolution microbiome analysis and employs 3D organotypic models to validate hypotheses. A key objective is replacing symptom-based diagnostics with metagenomic community state types (mgCSTs) that predict infection risk and BV recurrence, aiming to develop antibiotic-sparing interventions. Analysis of her recent publications reveals a strong emphasis on vaginal microbiome characterization through multi-omics integration, with consistent themes including pathogen-microbiome interactions, computational tool development (e.g., VALENCIA classifier), and translational applications for women's health. Her work spans methodological advances in low-biomass sample analysis, cross-population studies of microbiome-disease associations, and mechanistic investigations of host responses. Her scientific achievements have been recognized through: NIAID F32 Postdoctoral Fellowship (AI136400) NIAID K01 Career Development Award (AI163413) Dr. Holm actively mentors trainees in both bioinformatics and wet-lab techniques, emphasizing interdisciplinary skills for microbiome research. Her work is supported by the National Institute of Allergy and Infectious Diseases and focuses on translating discoveries into clinical applications for global reproductive health improvement. Her laboratory operates within the Institute for Genome Sciences at the Health Sciences Facility III, where it combines multi-omics data integration, epidemiological modeling, and in vitro experimental systems to advance understanding of mucosal pathogenesis and develop microbiome-informed diagnostics.

Steven K. Lowerمشاهده پروفایل

استاد

• Environmental Mineralogy
• Geological Microbiology
• Medical Microbiology
• +۴ مورد دیگر

Steven K. Lower is a Professor at The Ohio State University with appointments spanning the School of Environment and Natural Resources, School of Earth Sciences, and Department of Microbial Infection and Immunity. His interdisciplinary research bridges environmental science, earth sciences, and medical microbiology, focusing on the molecular interactions between microorganisms and mineral surfaces. Dr. Lower's educational background includes a B.S. in Biology & Geology, an M.S. in Environmental Chemistry from Kent State University, and a Ph.D. in Microbiology & Mineralogy from Virginia Tech. His career path took him from an Assistant Professor position at the University of Maryland (2001-2003) to his current professorship at Ohio State University (2003-present). His research interests center on environmental mineralogy and chemistry, geological and environmental microbiology, and medical microbiology. Dr. Lower specializes in studying how bacteria interact with mineral surfaces at the nanoscale, with particular focus on magnetotactic bacteria that orient along Earth's magnetic field and pathogenic bacteria like Staphylococcus aureus that form biofilms on medical implants. His laboratory employs atomic force microscopy and other nanoscale techniques to measure the fundamental forces governing these interactions. Analysis of Dr. Lower's recent publications reveals a strong interdisciplinary trend spanning environmental science, medical microbiology, and biophysics. His work connects fundamental physical principles with practical applications in environmental remediation and medical device safety. The research consistently applies nanoscale measurement techniques to understand bacterial behavior in both natural and clinical settings, with particular attention to how bacteria form aggregates and adhere to surfaces. Dr. Lower's scientific achievements have been recognized with several prestigious awards: National Science Foundation CAREER Award PECASE Award (presented by President Obama at the White House) Kavli Fellow, National Academy of Sciences Department of Energy (DOE) Best Research Award Clinical Research Forum Outstanding Research Award As a principal investigator, Dr. Lower has secured research funding from the National Science Foundation (NSF), National Institutes of Health (NIH), and Department of Energy (DOE). His laboratory maintains active collaborations across disciplines, particularly with his brother Brian H. Lower, and focuses on understanding the molecular mechanisms of bacterial adhesion to both natural mineral surfaces and medical implants. The research has significant implications for developing strategies to prevent bacterial infections on medical devices and understanding microbial processes in environmental systems.

• Bacteriology
• Farm Animals
• Internal Medicine
• +۵ مورد دیگر

Dr. Matheus de Oliveira Costa is a researcher at Utrecht University's Faculty of Veterinary Medicine , working in the Population Health Sciences department under the Farm Animal Health Care group. His research focuses on host-pathogen-microbiome interactions in veterinary diseases, particularly those affecting swine. 2011: DVM, Federal University of Minas Gerais 2016: PhD, University of Saskatchewan 2021: Diplomate in Swine Health Management, ABVP Dr. Costa's work spans Bacteriology , Internal Medicine , and Host-Pathogen Interactions , with expertise in in vitro disease models and pathophysiology . His recent publications examine porcine β-defensins , Streptococcal infections , and antimicrobial resistance , contributing to the PtS - Future Food Utrecht research theme. He has developed in vitro colon culture methods and studied metabolic responses to infections. His research aligns with One Health principles, connecting animal, human, and environmental health.

• Comparative Genomics
• Molecular Epidemiology
• Bioinformatics
• +۵ مورد دیگر

Aldert Zomer is an Associate Professor at the Faculty of Veterinary Medicine , Utrecht University, specializing in Infectious Diseases & Immunology . He is affiliated with the WHO Collaborating Centre for Campylobacter and Antimicrobial Resistance and serves as a Bioinformatics Consultant for Janssen Pharmaceuticals . His research focuses on bacterial (meta)genomic analysis for comparative genomics , molecular epidemiology , and genotype-phenotype associations in pathogens like Salmonella , Escherichia coli , and Campylobacter . PhD in Molecular Genetics from University of Groningen (2007) Postdoctoral work at University College Cork and Radboud University Medical Centre His research integrates bioinformatics , microbiome analysis , and machine learning to study antimicrobial resistance mechanisms, host-pathogen dynamics, and microbial ecology in veterinary and public health contexts. Current projects include Visiting Scientist at Quadram Institute (Norwich, UK) Leadership in Utrecht University's Research IT Committee He has developed open-source tools like RFPlasmid and Kaptive for genomic analysis and is actively involved in WHO's One Health AMR initiatives OIE Reference Laboratory for Campylobacter Teaching microbial genomics courses at Utrecht University

• Vector-borne and Zoonotic Diseases
• Innate Immunity and Immunology of Infections in Older Adults
• Microbial Pathogenesis
• +۴ مورد دیگر

Thilinie D Bandaranayake, MBBS, is an Assistant Professor of Medicine (Infectious Diseases) at Yale School of Medicine. She specializes in treating bloodstream infections, soft tissue/joint infections, hospital-acquired pneumonia, and HIV-related conditions. MBBS (University of Peradeniya, 2006) Residency (Norwalk Hospital, CT, 2013) Fellowship (Yale School of Medicine/Yale New Haven Hospital, 2015) Her research focuses on age-related immune dysfunction in infections like measles, adenovirus, and cytomegalovirus. She also investigates antimicrobial resistance , vector-borne diseases , and HIV treatment innovations through clinical trials. Recent publications analyze oritavancin tolerability (2024), adenovirus outcomes in adults (2024), leishmaniasis in pregnancy (2022), and Prototheca infections in transplant recipients (2015). Her work spans Tropical Medicine , Medical Informatics , and Immunosenescence . Clinically, she treats complex infections at Yale New Haven Hospital and Saint Raphael Campus. Board certified in Internal Medicine (2013) and Infectious Diseases (2015), she speaks English and Sinhalese.

• Bacterial genetics
• Bacterial sensory signal transduction
• Biofilms
• +۶ مورد دیگر

Dr. Sampriti Mukherjee is an Assistant Professor in the Department of Molecular Genetics and Cell Biology at the University of Chicago. Her research focuses on understanding how bacteria decode and integrate self-generated and environmentally-derived stimuli to control transitions between individual and collective behaviors, particularly in the context of biofilm formation and bacterial pathogenesis. Dr. Mukherjee received her BS and MS in Microbiology from the University of Calcutta (2007 and 2009), followed by a PhD in Microbiology from Indiana University (2014). She completed her postdoctoral training in Molecular Biology at Princeton University in 2020. Her laboratory employs a multidisciplinary approach combining bacterial genetics, molecular biology, biochemistry, microfluidics, fluorescence microscopy, and genome-scale studies to investigate bacterial signal detection, relay, and integration mechanisms. Her research has significant implications for developing strategies to combat antibiotic-resistant infections by targeting bacterial communication systems rather than bacterial growth directly. The work has revealed novel mechanisms of bacterial communication, including the discovery of new quorum-sensing autoinducers and their receptors, the integration of photosensing with quorum sensing, and the regulation of biofilm development through combinatorial control of multiple signaling pathways. Dr. Mukherjee's research has been recognized with several prestigious awards: Searle Scholars Program (2022-2025) NIH Pathway to Independence Award (K99/R00, 2018-2023) Life Sciences Research Foundation Postdoctoral Fellowship (2016-2019) She currently leads multiple NIH-funded research projects as Principal Investigator, including R35GM150803 "Probing the role of sensory cues in the regulation of bacterial biofilm development" (2023-2028) and R00GM129424 "A New Quorum-Sensing Autoinducer Acts with the RhlR Receptor to Control Virulence and Biofilms in Pseudomonas Aeruginosa" (2018-2023), demonstrating her significant contributions to the field of bacterial signal transduction and pathogenesis. Dr. Mukherjee's lab is part of the vibrant research community in the Department of Molecular Genetics and Cell Biology at the University of Chicago, collaborating with researchers studying bacterial pathogenesis, signal transduction, and microbial communities to advance our understanding of bacterial collective behaviors and their implications for human health.

Maria José Serol de Brito Correiaمشاهده پروفایل

دانشیار

• Microbiology
• Oral Microbiome
• Molecular Biology
• +۳ مورد دیگر

Maria José Serol de Brito Correia serves as an Associate Professor at the Faculty of Dental Medicine of the Catholic University of Portugal (UCP) in Viseu, where she has been a faculty member since April 2001. She coordinates the first cycle of the Integrated Master's degree in Dental Medicine and teaches Molecular Genetics and Oral Microbiology courses. Her educational background includes: PhD in Biology (2001) from City University of New York (recognized by Universidade do Algarve in Biology, specialty of Microbiology) Master's degree in Biology (1996) from City University of New York Degree in Marine Biology and Fisheries (1994) from Universidade do Algarve Dr. Correia's research program focuses on the ecology of the human microbiome and its relationship with the host, with particular emphasis on salivary diagnostics. She has developed an extensive research portfolio examining the oral cavity as a diagnostic window for systemic conditions, including diabetes, cardiovascular disease, and autism spectrum disorders. Her work bridges basic microbiology with clinical applications, developing bioinformatic tools like OralCard and SalivaPRINT for analyzing oral biomarkers. She has established community-based research partnerships with the Senior Activity program of Viseu municipality and the Association for Developmental Disorders and Autism (APPDA)-Viseu, demonstrating her commitment to translational research that directly benefits local populations. Analysis of her publication record reveals a consistent research trajectory focused on oral microbiome characterization, salivary biomarker discovery, and computational approaches to oral health diagnostics. Her work spans fundamental microbiology studies of oral pathogens to clinical applications of salivary diagnostics, with increasing emphasis on bioinformatics tools for oral health assessment. The progression of her research shows movement from basic characterization of oral microorganisms toward sophisticated diagnostic applications using proteomics and computational biology. Dr. Correia is an active member of the Interdisciplinary Research Center in Health (CIIS) at UCP, where she contributes to the SalivaTec laboratory's mission of developing saliva-based diagnostic approaches. Her collaborative work extends across disciplines, connecting dental medicine with molecular biology, bioinformatics, and public health research.

• Genetics of diabetes
• Insulin mutations
• Metabolic disorders
• +۳ مورد دیگر

Graeme Bell is a distinguished Professor in the Department of Human Genetics at the University of Chicago, specializing in the genetics of diabetes and metabolic disorders. He serves as the Pres Kovler Family Distinguished Service Professor and has made significant contributions to understanding the genetic basis of diabetes. His research spans molecular mechanisms of insulin production, beta cell dysfunction, and the genetic architecture of type 2 diabetes. Education: B.Sc. in Zoology from University of Calgary (1968) M.Sc. in Biology from University of Calgary (1971) Ph.D. in Biochemistry from University of California San Francisco (1977) Dr. Bell's research program focuses on the genetics of diabetes, particularly investigating insulin mutations, MODY (Maturity Onset Diabetes of the Young), and the genetic architecture of type 2 diabetes. His work has elucidated molecular mechanisms underlying beta cell dysfunction and identified numerous genetic variants associated with diabetes susceptibility. Through extensive genomic studies, he has contributed to our understanding of how genetic variations influence glucose metabolism, insulin secretion, and diabetes pathogenesis across diverse populations. Dr. Bell's extensive publication record demonstrates a strong focus on diabetes genetics through large-scale genomic studies, functional characterization of diabetes-associated mutations, and investigation of population-specific genetic factors. His work spans basic molecular mechanisms of insulin production to population-level genetic architecture studies, with particular emphasis on trans-ethnic analyses that reveal both shared and population-specific genetic factors in diabetes. Scientific Awards and Honors: Pres Kovler Family Distinguished Service Professor, The University of Chicago (2016) National Academy of Medicine (1998) American Academy of Arts and Sciences (2008) Fellow of the American Association of the Advancement of Science (2011) Manpei Suzuki International Prize for Diabetes Research (2012) The Banting Medal for Scientific Achievement of the American Diabetes Association (2013) Throughout his career, Dr. Bell has secured substantial NIH funding as Principal Investigator for numerous research projects investigating the genetic basis of diabetes. His laboratory has been instrumental in establishing the genetic architecture of type 2 diabetes through large-scale genomic studies. He has mentored numerous researchers in the field and collaborated extensively with international consortia including the T2D-GENES Consortium and SIGMA T2D Genetics Consortium. His work has significantly advanced our understanding of how genetic variations contribute to diabetes susceptibility and pathogenesis. Dr. Bell leads a research team within the Department of Human Genetics at the University of Chicago that focuses on integrating genomic, molecular, and clinical approaches to understand diabetes pathogenesis. His laboratory has been at the forefront of identifying and characterizing genetic variants associated with diabetes, with particular expertise in monogenic forms of diabetes and the complex genetic architecture of type 2 diabetes.

Bahtiyar Yilmazمشاهده پروفایل

استاد

• Microbiota
• Infectious Diseases
• Immunology
• +۴ مورد دیگر

Prof. Dr. Bahtiyar Yilmaz is a Group Leader at the Department of Biomedical Research (DBMR) at the University of Bern. His research focuses on the interplay between the gut microbiota, immunity, and disease, spanning infectious diseases, neurodegenerative disorders, and inflammatory bowel disease (IBD). University: University of Bern Department: Department of Biomedical Research (DBMR) Research Interests: Yilmaz investigates how gut microbiota influences health and disease. His work explores microbial translocation , gut-liver and gut-brain axes , antimicrobial resistance in wildlife , and microbiota-driven immune responses in conditions like Alzheimer’s, diabetes, and IBD. Recent Publications (all in 2025) highlight his multidisciplinary approach, including studies on: Microbial drivers of surgical site infections Chromatin accessibility in microglia linked to Alzheimer’s Antimicrobial resistance in livestock and wildlife Small intestinal microbiota dynamics under dietary changes Gut microbiota’s role in valvular heart disease Evolutionary adaptation in gut microbes His work bridges microbiology, immunology, and computational modeling to address clinical challenges in infectious and chronic diseases.

Marc Lecuitمشاهده پروفایل

استاد

• Microbial Pathogenesis
• Host-Pathogen Interactions
• Infectious Diseases
• +۴ مورد دیگر

Marc Lecuit is a Professor at Institut Pasteur , leading the Biology of Infection Unit (Inserm U1117) . His research focuses on host-pathogen interactions , particularly for Listeria monocytogenes and Chikungunya virus , investigating mechanisms of microbial translocation across mucosal barriers, immune evasion, and age-dependent susceptibility to infections. Research Themes : Host-pathogen interactions, microbial pathogenesis, neuroinvasion, immunology, emerging infectious diseases Affiliations : Institut Pasteur, Inserm, Labex IBEID Projects : ERC-PoC PRESERVE, ERC-CoG INVADIS, Human and ruminant neurolisteriosis study His recent work explores alphavirus transmission via intercellular extensions , virulence heterogeneity in Listeria , and microbiota-driven pathogen dissemination . Publications span high-impact journals like Nature Microbiology , Lancet Infectious Diseases , and Science Immunology . Current advisees include PhD candidates and postdoctoral researchers studying bacterial pathogenesis, viral transmission, and host immune responses. Collaborations span global institutions including Oxford University, Swiss National Science Foundation, and La Réunion Island health authorities.

Marc Vallsمشاهده پروفایل

استاد

• Plant Pathology
• Molecular Plant-Microbe Interactions
• Bacterial Diseases in Plants
• +۳ مورد دیگر

Marc Valls is a Full Professor at the University of Barcelona (UB) , leading the research program Plant Responses to Stress and the Malalties bacterianes i proteòstasi de les plantes group. His research focuses on bacterial plant pathogens, particularly Ralstonia solanacearum , and mechanisms of plant proteostasis and stress response. He works in the CRAG (Centre de Recerca en Agrigenòmica) Building on the UAB Campus. Research Interests : Marc Valls investigates plant-pathogen interactions, emphasizing bacterial wilt resistance, metacaspase functions in cell death regulation, and effector protein dynamics. His work spans Molecular characterization of plant immune responses Role of proteases in disease susceptibility Transcriptomic and metabolomic profiling during infection Development of hydroponic infection models Genetic determinants of pathogen virulence Chemical barriers in vascular immunity Scientific Trends : Recent publications highlight his focus on Ralstonia solanacearum virulence, plant immune signaling (e.g., FERONIA pathways), effector-triggered immunity, and stress-induced proteostasis. Key themes include cytokinin signaling, ligno-suberin coatings, and metacaspase-mediated cell death. Collaborative efforts target type III secretion inhibitors for disease management. Scientific Awards : Premio al mejor póster presentado en el XXXVI Congreso, Valencia (2015) Labs & Teams : Based in the CRAG Building (Lab 1.03), his team explores plant stress responses and bacterial disease mechanisms. Contact: Office 1.13, +34 935636600 ext 3132 (Office), +34 935636600 ext 3121 (Lab).

Chiara Crestaniمشاهده پروفایل

پژوهشگر

• Microbial Genomics
• Antibiotic Resistance
• Epidemiology
• +۳ مورد دیگر

Chiara Crestani is a Medical Scientist and Project Manager at Institut Pasteur (France), specializing in microbial genomics and public health. She serves as Principal Investigator for the project Oxford Nanopore sequencing for detection and surveillance of pathogens , focusing on antibiotic resistance and pathogen characterization. Her academic background includes a PhD in Infectious Diseases (Bacterial Genomics) from the University of Glasgow (2017-2021) and a Doctor of Veterinary Medicine from Università di Bologna (2010-2015). Her research spans genomic epidemiology , antibiotic resistance surveillance , and pathogen detection , with a focus on Corynebacterium and Group B Streptococcus . She leads initiatives like KlebNet , a One Health network for Klebsiella research, and contributes to Surveillance of Antibiotic Resistance in Africa (SARA) . Her recent work leverages long-read sequencing to enhance pathogen diagnostics and genomic classification systems. Key projects : Oxford Nanopore sequencing, KlebNet, SARA, Diphtheria/Corynebacteria genomics Technical expertise : Bioinformatics, bacterial genomics, pathogen characterization